Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.
about
Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Challenges and Opportunities in Drug Delivery for Wound HealingAre Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and PerspectivesChemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous ScarringChemokine Regulation of Angiogenesis During Wound HealingThe Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus AttenuationNitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review)Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusTopical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trialRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationCirculating and tissue resident endothelial progenitor cellsNotch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potentialAntimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healingOxidative stress and diabetic complicationsThe potential effect of biological sealants on colorectal anastomosis healing in experimental research involving severe diabetes.Chronic wound repair and healing in older adults: current status and future research.Genetic and epigenetic events in diabetic wound healing.Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis.Noncontact, low-frequency ultrasound therapy enhances neovascularization and wound healing in diabetic mice.The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteinsClinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexityDownregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells.cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesisComparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic controlConcise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular FractionRecovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activationCD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosageEffect of vitamin D on endothelial progenitor cells functionIdentification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing.Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarringUnacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetesLocal injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expressionFactors affecting wound healing.Characterization of endothelial progenitor cells mobilization following cutaneous wounding.Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells.Molecular insights and therapeutic targets for diabetic endothelial dysfunction.Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cellsEnhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging.
P2860
Q26745523-E443EE33-FEE7-44AA-B8B4-03C299BAD72BQ26767057-82C918C3-48CE-45F8-AFDA-1E16C8B6B0F5Q26778217-A75C0E58-D612-47D8-BB03-6BB22135FAAFQ26778684-B7288D10-5133-4D41-B69E-63CB86AA7E5DQ26778691-412F5A6A-92AA-41AD-AE42-3F34092AFA5BQ26795464-E69EF23F-6DBD-48CC-AA6C-E4622F2AD7E0Q26823520-89AC01B9-3141-44BF-998E-44886273BA2CQ26851688-5B8C0E29-7B7B-48D6-921B-01E8631C9C6EQ26864580-445E0589-FE5B-44FC-A34E-B0E909BE8B6AQ27302994-157CDF8F-8D02-4C99-94EE-80616002AF73Q28078462-6A3E8B9A-4D91-4666-81B7-A741F792408BQ28293322-FA9E1CC7-0A21-4429-8ECE-8C9FB264149FQ28474088-EAF79845-629D-4B1B-8CC7-B0B99A0582BAQ28478087-6E4E206F-DD89-4799-B043-F57E2CE905D5Q29615423-C3ACAD5C-1D2C-424D-A5DA-F177D51AF2B2Q30240236-0AC8DDDD-59E1-4888-A528-FC28A59AA3B9Q30360825-0E9ADDBB-6BB4-4F97-BD01-71BB950A6213Q30397422-2989C93C-468B-4A65-BEE4-88686D964792Q30486693-348142B3-AE0D-4B6B-AB73-E142D601DEF4Q30648334-D705B53F-62CF-45E9-B583-451B79656353Q33354115-509809E0-09B3-4662-AB3F-216C69B27E2EQ33359352-4B4B41B2-AFDF-491B-A1B0-E926565A7C94Q33410261-019FDA10-21EE-4FAA-8F3E-A52D6AED638FQ33418301-E6E7352F-66F0-4944-B96A-85FF8E69B78EQ33550596-97652EB8-9119-44F9-9469-4CAAB22C8BE6Q33553011-20B370D9-5402-4968-A936-BC9C19158BEFQ33553042-56095DFC-6508-44E1-9906-E6E1C1E45164Q33674663-2A351554-5027-4A71-91DD-252DD8E782E6Q33681013-F3F2D168-7298-4AAC-9F4E-0C817DB079C1Q33699531-94B8DB7F-19AC-4D05-ADA8-2E372E339163Q33706243-309AA09C-ED63-4F34-9B6F-60BA7F6751ABQ33745172-C5DC7430-F4BF-433A-AF5A-8DCE586238EFQ33750608-D9E0C4BB-F5ED-4299-A5A2-3B9EC87F296EQ33807106-9F15EE84-C19A-4ED0-AC9A-4CFA173C9E4CQ33993981-F8D48C6B-83A9-488B-A9DA-28876BE00028Q34006090-59931A55-E103-4F35-B695-368287D3F2FFQ34009778-E809B95E-62B6-4438-819C-6CF79FA8A38BQ34022332-2FB05414-10CE-44C4-82A8-CE0D95413BA4Q34116953-30EC8361-56DE-4985-A812-209DD3050DF0Q34158926-E9C90634-4E74-4066-918E-DCA9BE00B36E
P2860
Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@en
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@nl
type
label
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@en
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@nl
prefLabel
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@en
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@nl
P2093
P2860
P356
P1476
Diabetic impairments in NO-med ...... by hyperoxia and SDF-1 alpha.
@en
P2093
April Nedeau
Donald G Buerk
Haiying Chen
Katherine A Gallagher
Lee J Goldstein
Omaida C Velazquez
Stephen R Thom
Zhao-Jun Liu
P2860
P304
P356
10.1172/JCI29710
P407
P577
2007-05-01T00:00:00Z